Medical Health & Life Science Research News

Report explores the long acting injectable anti-psychotic market

Medical Market Research

The report assesses the key opportunities in the long acting injectable anti-psychotic market and outlines the factors that are and will be driving the growth of the industry. The report profiles key players in the industry such as Johnson & Johnson, Eli Lily and Company, Alkermes Public Limited Company and Lundbeck.

- Advertising -

Research By Markets adds "Global Long Acting Injectable Anti…casts (2017-2021)" to its online repository. The report provides analysis of the global injectable anti-psychotic market, with detailed analysis of market size and growth, and segmentation of the industry.

The report also includes a detailed regional analysis of the long acting injectable anti-psychotic market in the region of the US. Under competitive landscape, different products in the long acting injectable anti-psychotic market have been compared on the basis of different parameters such as dosing frequency, patent expiry, injection sites, label, storage, needles and available strengths.

- Advertising -

Also, a financial comparison of long acting injectable market players in the US has been done.

Johnson & Johnson, Eli Lily and Company, Alkermes Public Limited Company and Lundbeck are some of the key players operating in the global long acting injectable anti-psychotic market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

Access Report: www.researchbymarkets.com/report/g…17-2021-4964.html

Executive Summary

Anti-psychotic refers to a class of medicine used for the treatment of psychosis and various other emotional and mental conditions. Psychosis consist of delusions, hallucinations, paranoia and disordered thought.

It is a condition in which a person experiences thought disorder and personality changes. Long acting injectable anti-psychotics are a sub type of antipsychotics which were primarily developed to improve the treatment of schizophrenia.

The global long acting injectable anti-psychotic market can be studied on the basis of different products and on the basis of prescription. These products are different types of long acting injectable anti-psychotic namely Invega Sustenna/ Trinza, Risperdal Consta, Abilify Maintena, Zyprexa, Aristada and many more.

The Global Long Acting Injectable Anti-psychotic Market is expected to increase at a healthy rate during the forecast period (2017-2021). The global long acting injectable anti-psychotic market is supported by various growth drivers, such as increasing cases of schizophrenia, rising number of bipolar disorder patients and non adherence to oral anti-psychotic.

However, side effect associated with anti-psychotic and patent expiry of some of the leading brands are some of the challenges faced by the market. Aging dernography, grant of approval to Trevicta in European Commission, third party proprietary technologies and label expansion of Abilify Maintena are some of the latest trends in the global long acting injectable anti-psychotic market.

Country Coverage

United States of America

Company Coverage

Johnson & Johnson
Eli Lily and Company 
Alkeremes Public Limited Company
Lundbeck

News From

Research By MarketsResearch By Markets
Category: Market Research Publishers and RetailersCompany profile: Research by Markets is an online Market Research Report Repository. Our repository contains reports segmented by Geography and Industry. We cover all major Industry Verticals - Information Technology, Semiconductor, Electronics, Manufacturing, Food & Beverages, Telecommunications, Healthcare, Pharmaceutical, Automotive, BioTechnology, Energy & Power, Banking and many more. We have dedicated Account Managers for Corporate Clients to ensure seamless customer support. Corporates can als ...